MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Spyre Therapeutics, Inc. (NASDAQ: SYRE), formerly, Aeglea BioTherapeutics Inc. (NASDAQ: AGLE)*
Finance & Acquisitions: Aeglea
Parents
Spyre Therapeutics, Inc. (NASDAQ: SYRE), formerly, Aeglea BioTherapeutics Inc. (NASDAQ: AGLE)*
Children
2025: Spyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Aeglea BioTherapeutics Holdings has completed a $12 million round of funding (2014)
Aeglea BioTherapeutics_Analysts_www.nasdaq.com
research.investors.com
Jumps
*Key People: Aeglea
Organization & Developments: Aeglea